English | Español
Patient Daily | Mar 22, 2026

Pharma industry may see larger mergers as companies face patent cliffs and pricing shifts
Patient Daily | Mar 22, 2026

Kennedy’s vaccine agenda faces setback as obesity drug developments continue
Patient Daily | Mar 22, 2026

TerraPower announces $450 million radioisotope plant in Philadelphia
Patient Daily | Mar 22, 2026

R1 Therapeutics raises $77.5 million in series A funding for kidney disease drug
Patient Daily | Mar 22, 2026

FDA approves Protagonist and J&J’s Icotyde for plaque psoriasis treatment
Patient Daily | Mar 22, 2026

FDA approves Johnson & Johnson's Icotyde for plaque psoriasis treatment
Patient Daily | Mar 22, 2026

Johnson & Johnson leads pharma revenue as Lilly rises on obesity drug sales
Patient Daily | Mar 22, 2026

Studies link adult thymus health to longevity and disease risk, researchers say

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'